Abstract:Purpose of review: Opioid receptors are widely expressed in the human brain. A number of features commonly associated with drug use disorder, such as difficulties in emotional learning, emotion regulation and anhedonia, have been linked to endogenous opioid signalling. Whereas chronic substance use and misuse are thought to alter the function of the mu-opioid system, the specific mechanisms are not well understood. We argue that understanding exogenous and endogenous opioid effects in the healthy human brain is an essential foundation for bridging preclinical and clinical findings related to opioid misuse. Here, we will examine psychopharmacological evidence to outline the role of the mu-opioid receptor (MOR) system in the processing of threat and reward, and discuss how disruption of these processes by chronic opioid use might alter emotional learning and reward responsiveness. Recent findings: In healthy people, studies using opioid antagonist drugs indicate that the brain's endogenous opioids downregulate fear reactivity and upregulate learning from safety. At the same time, endogenous opioids increase the liking of and motivation to engage with high reward value cues. Studies of acute opioid agonist effects indicate that with non-sedative doses, drugs such as morphine and buprenorphine can mimic endogenous opioid effects on liking and wanting. Disruption of endogenous opioid signalling due to prolonged opioid exposure is associated with some degree of anhedonia to non-drug rewards; however, new results leave open the possibility that this is not directly opioid-mediated. Summary: The available human psychopharmacological evidence indicates that the healthy mu-opioid system contributes to the regulation of reward and threat processing. Overall, endogenous opioids can subtly increase liking and wanting responses to a wide variety of rewards, from sweet tastes to feelings of being connected to close others. For threat-related processing, human evidence suggests that endogenous opioids inhibit fear conditioning and reduce the sensitivity to aversive stimuli, although inconsistencies remain. The size of effects reported in healthy humans are however modest, clearly indicating that MORs play out their role in close concert with other neurotransmitter systems. Relevant candidate systems for future research include dopamine, serotonin and endocannabinoid signalling. Nevertheless, it is possible that endogenous opioid fine-tuning of reward and threat processing, when unbalanced by e.g. opioid misuse, could over time develop into symptoms associated with opioid use disorder, such as anhedonia and depression/anxiety.

Mu-opioid receptor system modulates responses to vocal bonding and distress signals in humans

Decoding brain basis of laughter and crying in natural scenes

Endogenous opioid receptor system mediates costly altruism in the human brain

Mu Opioid Receptor-Expressing Neurons in the Dorsal Raphe Nucleus Are Involved in Reward Processing and Affective Behaviors

Endogenous mu-opioid modulation of social connection in humans: a systematic review and meta-analysis

Opioid system and human emotions

Pleasurable music activates cerebral μ-opioid receptors: A combined PET-fMRI study

Mu-opioid receptor activation potentiates excitatory transmission at the habenulo-peduncular synapse

Seasonal variation in brain mu-opioid receptor availability

Social laughter is correlated with an elevated pain threshold

Humor and emotion: Quantitative meta analyses of functional neuroimaging studies

The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies

Individual differences in laughter perception reveal roles for mentalizing and sensorimotor systems in the evaluation of emotional authenticity

A mesocorticolimbic signature of pleasure in the human brain

Intranasal oxytocin modulates neural functional connectivity during human social interaction

Gating of social reward by oxytocin in the ventral tegmental area

Oxytocin receptor gene and parental bonding modulate prefrontal responses to cries: a NIRS Study

Complex opioid driven modulation of glutamatergic and cholinergic neurotransmission in a GABAergic brain nucleus associated with emotion, reward and addiction.

Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety

An investigation of laughter and crying : from behavioural, physiological and neuroimaging studies

Effects of dopamine and opioid receptor antagonism on the neural processing of social and nonsocial rewards